---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-043491"
form_type: "8-K"
ticker: "PYXS"
cik: "0001782223"
company_name: "Pyxis Oncology, Inc."
filed_at: "2025-03-24T23:59:59+00:00"
generated_at: "2026-05-24T06:48:05.807837+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Pyxis Oncology posts updated investor presentation; no specific new data disclosed

## Summary
- Updated corporate presentation dated March 24, 2025, posted on company IR website.
- Presentation slide deck title references 'Building a Differentiated ADC Company'.
- No financial results, pipeline data, or strategic updates provided in the filing.
- Filing does not include any earnings, guidance, or material business developments.

## SEC filing metadata
- accession: 0000950170-25-043491
- form_type: 8-K
- ticker: PYXS
- cik: 0001782223
- company_name: Pyxis Oncology, Inc.
- filed_at: 2025-03-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782223/000095017025043491/0000950170-25-043491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782223/000095017025043491/pyxs-20250324.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-043491
- JSON: https://secwatch.observer/filing/0000950170-25-043491.json
- Plain text: https://secwatch.observer/filing/0000950170-25-043491.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.